an agent used in cancer chemotherapy that acts by disrupting the microtubular network in cells that is essential for mitotic and interphase cellular functions. Docetaxel binds to free tubulin and promotes the assembly of tubulin into stable microtubules while simultaneously inhibiting their disassembly. This leads to the production of microtubule bundles without normal function and to the stabilization of microtubules, which results in the inhibition of mitosis in cells.
A chemotherapy agent that stops or slows the growth of cancer cells and is used to treat breast cancer that has spread to other parts of the body.
Docetaxel is the generic name of a drug called Taxotere® (docetaxel). This drug interferes with the growth of cancer cells, and it is used to treat breast cancer. It may be used in combination with other drugs, including XELODA.
A drug used together with other drugs to treat certain types of breast cancer, stomach cancer, and prostate cancer. It is also being studied in the treatment of other types of cancer. Docetaxel belongs to the family of drugs called mitotic inhibitors. Also called Taxotere.
An anticancer drug that belongs to the family of drugs called mitotic inhibitors.
Docetaxel is a clinically well established anti-neoplastic medication used mainly for the treatment of breast, ovarian, and non-small cell lung cancer.Lyseng-Williamson KA, Fenton C. Docetaxel: a review of its use in metastatic breast cancer. Drugs 2005;65(17):2513-31.Clarke SJ, Rivory LP.